The global Amphotericin B market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Amphotericin B market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/7870719/global-amphotericin-b-forecast-2023-2030-879
The China market for Global Amphotericin B market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Amphotericin B market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. The antibiotic is without effect on bacteria, rickettsiae, and viruses.
This report aims to provide a comprehensive presentation of the global market for Amphotericin B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amphotericin B.
This report contains market size and forecasts of Amphotericin B in global, including the following market information:
- Global Amphotericin B Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Static Drops Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Amphotericin B include Bristol-Myers Squibb, Matinas BioPharma, Nanox, Nanomerics, DNDi, Abzena, Bharat Serums, Jina Pharma and Astellas Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Amphotericin B companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amphotericin B Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Amphotericin B Market Segment Percentages, by Type, 2022 (%)
- Static Drops
- Atomization Inhalation
- Local Lesion Injection
- Other
Global Amphotericin B Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Amphotericin B Market Segment Percentages, by Application, 2022 (%)
- Vaginitis
- Candida Infection
- Leishmaniasis
- Kala-Azar
- Cryptococcal Infection
- Aspergillus Infection
- Other
Global Amphotericin B Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Amphotericin B Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Amphotericin B revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Amphotericin B revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol-Myers Squibb
- Matinas BioPharma
- Nanox
- Nanomerics
- DNDi
- Abzena
- Bharat Serums
- Jina Pharma
- Astellas Pharma
- Leadiant Biosciences
- Kadmon Corporation (Eli Lilly and Company)
- InterMune
- Sterimax Inc
- X-GEN Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Amphotericin B, market overview.
Chapter 2: Global Amphotericin B market size in revenue.
Chapter 3: Detailed analysis of Amphotericin B company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Amphotericin B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Get the Complete Report & TOC @ https://www.statsmarketresearch.com/global-amphotericin-b-forecast-2023-2030-879-7870719
Table of content
1 Introduction to Research & Analysis Reports
1.1 Amphotericin B Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Amphotericin B Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Amphotericin B Overall Market Size
2.1 Global Amphotericin B Market Size: 2022 VS 2030
2.2 Global Amphotericin B Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Amphotericin B Players in Global Market
3.2 Top Global Amphotericin B Companies Ranked by Revenue
3.3 Global Amphotericin B Revenue by Companies
3.4 Top 3 and Top 5 Amphotericin B Companies in Global Market, by Revenue in 2022
3.5 Global Companies Amphotericin B Product Type
3.6 Tier 1, Tier 2 and Tier 3 Amphotericin B Players in Global Market
3.6.1 List of Global Tier 1 Amphotericin B Companies
3.6.2 List of Global Tier 2 and Tier 3 Amphotericin B Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Amphotericin B Market Size Markets, 2022 & 2030
4.1.2 Static Drops
Customize/Section/Part Purchase @ https://www.statsmarketresearch.com/chapters-purchase/7870719/global-amphotericin-b-forecast-2023-2030-879
CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414
Similar Reports:
Amphotericin B Market, Global Outlook and Forecast 2023-2030
Global Amphotericin B Market Insights and Forecast to 2028
Amphotericin B Market - Global Outlook and Forecast 2022-2028
Global Amphotericin B Market Size, Status and Forecast 2021-2027